PeerDirect

Medical News Podcast

Health EN ↓ Odcinki: 449

The Medical News Podcast by PeerDirect delivers news and interviews with clinical thought leaders and researchers to keep you informed of the latest breakthroughs, guidelines, and insights in your specialty. Designed for clinicians with stories selected by the PeerDirect editorial board. Visit us at peerdirect.com to sign-up for our newsletter.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.peerdirect.com

Autor

PeerDirect

Kategoria

Health

Strona podcastu

www.peerdirect.com

Ostatni odcinek

6 paź 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Leukemic Transformation in Myelofibrosis: Risks, Realities, and Evolving Strategies 19.05.2025

Drs. Bose and Pemmaraju discuss leukemic transformation in patients with myelofibrosis, reviewing its incidence, as well as risk factors, treatment, and prognosis.

Understanding Secondary Myelofibrosis: Diagnosis, Treatment, and Prognosis 16.05.2025

Drs. Bose and Pemmaraju review secondary myelofibrosis arising from polycythemia vera or essential thrombocythemia and how it differs from primary myelofibrosis that develops de novo.

How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations? 14.05.2025

Maternal RSV vaccines and infant nirsevimab led to major drops in hospitalizations among infants ≤7 months, especially those ≤2 months old. The CDC’s 2025 nPEP guidelines stress starting HIV prevention within 72 hours of exposure, with rapid testing and follow-up care. Treatment should begin without delay, and patients at ongoing risk should transition to PrEP. Surgical site infections after color...

Migraine Missteps: Common Diagnostic Pitfalls and How to Avoid Them 09.05.2025

Drs. Starling and VanderPluym discuss common diagnostic pitfalls in migraine medicine and how the misinterpretation of symptoms can lead to unnecessary testing or incorrect treatments.

Game Changer: Are CGRP Inhibitors the New First Line for Migraine Prevention? 07.05.2025

Drs. VanderPluym and Starling review the updated position statement from the American Headache Society indicating that CGRP-targeting migraine therapies should be considered as a first-line option.

Could a new HER2-targeted therapy change outcomes in previously treated NSCLC? 06.05.2025

This episode features the Beamion LUNG-1 trial, where zongertinib showed a 71% response rate in previously treated HER2-mutant NSCLC patients. The EAGLE-1 trial found gepotidacin non-inferior to standard treatment for urogenital gonorrhoea, with a 92.6% success rate. The U.S. Department of Health and Human Services and NIH launched the Generation Gold Standard initiative, a universal vaccine platf...

Lifestyle and Cognitive Health: A discussion with Drs. Elizabeth Kensinger and Andrew Budson 01.05.2025

Elizabeth Kensinger, PhD and Andrew Budson, MD explain how healthy lifestyle habits, memory offloading strategies, and turning facts into stories can support cognitive aging. They stress that enriching and novel activities are more effective for brain health than most apps. Dr. Budson supports the theory that beta amyloid defends against brain infections, linking it to viral triggers of Alzheimer'...

Could measles become endemic in the U.S. again within 25 years? 30.04.2025

A JAMA model warns measles could become endemic in the U.S. within 21 years if MMR vaccination rates don't rise, with over 850,000 projected cases. A Phase 3 NEJM trial found brensocatib reduced exacerbations in non-CF bronchiectasis. An EPIC study correlated higher breast cancer risk to higher education levels, beyond lifestyle and reproductive factors.

What does Mexico’s first fatal H5N1 avian flu case tell us about current risks to humans? 22.04.2025

Mexico’s first fatal H5N1 case involved a healthy child and highlights localized risk despite low global concern. Long-term antidepressant use was linked to higher sudden cardiac death risk, especially in younger adults. A U.S. study found 25% of adults with very high LDL cholesterol lacked statin treatment. These stories reveal persistent gaps in infection control, cardiac monitoring, and prevent...

Could genetic testing improve prostate cancer screening beyond PSA? 15.04.2025

A polygenic risk score significantly improved prostate cancer detection beyond PSA testing, identifying more treatable and aggressive cancers in high-risk men. New WHO guidelines aim to reduce global meningitis deaths by standardizing early diagnosis, treatment, and care across settings. GLP-1 receptor agonists and SGLT2 inhibitors were linked to reduced Alzheimer's risk, with GLP-1s showing the m...

Mary Beth Cicero on Reimagining the IUD: A Painless Future for Contraception 10.04.2025

Mary Beth Cicero, co-founder of Three Daughters, shares how her passion for women's health led to the development of a new frameless, self-assembling magnetic IUD designed to significantly reduce the pain of insertion and retrieval. The device, inspired by embryo transfer techniques and using copper as its active ingredient, aims to improve comfort, eliminate strings, and offer a more body-conform...

HER2+ Lung Cancer Treatment: Past, Present, and Future 02.04.2025

Drs. Yu and Sabari trace the evolution of HER2-mutant lung cancer treatment from chemotherapy to targeted therapies, highlighting key advancements, challenges, and patient responses. They also explore emerging treatment strategies, resistance mechanisms, and the future of personalized therapy based on biomarkers and co-mutations.

Can statins reduce liver cancer risk in patients with chronic liver disease? 01.04.2025

A study published in JAMA Internal Medicine found that statin use in patients with chronic liver disease was associated with a lower risk of liver cancer and hepatic decompensation, suggesting potential protective effects beyond lipid management. Surveys by the Annenberg Public Policy Center revealed widespread misinformation about the risks of consuming raw milk, highlighting the need for public...

HER2 Alterations in Lung Cancer 31.03.2025

Drs. Sabari and Yu discuss the molecular landscape of HER2-mutant lung cancer, including its genomic characteristics, common co-mutations, and differences between HER2 mutations and HER2 amplification. This discussion also explores the prevalence and clinical patterns of HER2 mutations, their oncogenic mechanisms, their impact on tumor behavior and metastases, and potential environmental or geneti...

HER2 Biomarker Testing in Lung Cancer 28.03.2025

Helena Yu, MD and Joshua Sabari, MD explore the importance of testing for HER2 alterations in lung cancer; how HER2 positivity influences clinical decision-making; and the key methods used for detection, including immunohistochemistry, fluorescence in situ hybridization, and next-generation sequencing. It also addresses challenges in standardizing HER2 testing, disparities in access to biomarker t...

Migraine: Updates from the 2024 European Headache Congress 27.03.2025

Carrie Dougherty, MD, FAHS and Jessica Ailani, MD review migraine abstracts from the 2024 European Headache Congress.

Could a new combination improve first-line therapy for myelofibrosis? 26.03.2025

A phase 3 study showed that combining pelabresib with ruxolitinib significantly improved spleen volume reduction and symptom relief in myelofibrosis patients compared to ruxolitinib alone, offering a promising new treatment option. Long-term use of gantenerumab may delay Alzheimer's dementia onset in individuals with inherited Alzheimer's, supporting the amyloid hypothesis and paving the way for f...

Migraine Debates: Initial Preventive Therapy and Status Migraine 25.03.2025

Jessica Ailani, MD and Carrie Dougherty, MD, FAHS debate initial preventive treatment for migraine and the in-clinic management of status migraine.

Pharmacological Management of Postpartum Depression: Pros and Cons 24.03.2025

Drs. Lebin and Nagle-Yang discuss the pharmacological management of PPD, with a focus on the risks and benefits of selective serotonin reuptake inhibitors (SSRIs) and zuranolone.

Barriers to Care Engagement for Postpartum Depression 21.03.2025

Drs. Nagle-Yang and Lebin discuss the barriers to care engagement for patients with PPD, including such factors as stigma, fear of judgement, and access to treatment.

Suicide Risk in Postpartum Depression: Screening and Management 20.03.2025

Sarah Nagle-Yang, MD and Lindsay Lebin, MD review the screening, impact, and management of suicide risk in patients with PPD, highlighting effective prevention strategies.

Could GLP-1 receptor agonists reduce the risk of blood cancers in type 2 diabetes patients? 18.03.2025

A study suggests GLP-1 receptor agonists may reduce hematologic cancer risk in type 2 diabetes patients by 54% compared to insulin. Two individuals have achieved functional HIV cures through stem cell transplants, offering insights into cure strategies. Additionally, women with dense breasts face double the risk of breast cancer and reduced mammogram accuracy, supporting FDA regulations for breast...

Can AI reduce false positives and biopsies in breast ultrasound exams? 11.03.2025

An AI system trained on breast ultrasound studies showed promise in reducing false positives and biopsies by over 37% and 28%, respectively, while maintaining sensitivity, potentially aiding clinical decision-making. Second, nirsevimab demonstrated effectiveness in preventing RSV infections and hospitalizations among infants, with protection waning over time but remaining significant. Lastly, brea...

Osteoporosis: Common Questions and Clinical Conundrums 10.03.2025

Drs. McClung and Singer delve into common questions and clinical conundrums encountered in managing osteoporosis and fractures, including calcium use and dental procedures, in patients with osteoporosis.

Operationalization of a Bisphosphonate “Drug Holiday” 07.03.2025

Drs. Singer and McClung discuss the operationalization of a bisphosphonate “drug holiday” in people treated with this class of osteoporosis medication. They address questions regarding patient selection criteria, duration of the holiday, and strategies for determining when and with what medication treatment should be resumed.

Słuchaj podcastu Medical News Podcast w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS